- Release Date: 14/08/24 10:40
- Summary: Significant CRO-67 Results in Pancreatic Cancer Studies
- Price Sensitive: Yes
- Download Document 229.19KB
- Forums
- ASX - By Stock
- NOX
- Ann: Significant CRO-67 Results in Pancreatic Cancer Studies
NOX
noxopharm limited
Add to My Watchlist
2.00%
!
9.8¢

Ann: Significant CRO-67 Results in Pancreatic Cancer Studies
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $28.63M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.8¢ | $1.675K | 17.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 105400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.100 |
2 | 75497 | 0.098 |
1 | 50700 | 0.097 |
1 | 8152 | 0.092 |
1 | 11111 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 105400 | 1 |
0.110 | 31000 | 2 |
0.115 | 55816 | 3 |
0.120 | 15000 | 1 |
0.130 | 5500 | 1 |
Last trade - 10.09am 05/09/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online